Aug 25 2010
Perrigo Company (Nasdaq: PRGO; TASE) announced it received FDA clearance on August 23, 2010 to manufacture infant formula liquid concentrate and ready-to-use products through its partner Kerry Proteins and Nutritionals located in Sainte Claire, Quebec. Perrigo received clearance to market the following new products:
- Milk-Based Infant Formula with ARA and DHA, Concentrate in a 13 oz multilayer high-barrier polypropylene bottle
- Milk-Based Infant Formula with ARA and DHA, Ready-to-Use Infant Formula in an 8 oz multilayer high-barrier polypropylene bottle
- Milk-Based Organic Infant Formula with ARA/DHA, Liquid Ready-to-Feed Infant Formula in an 8 oz multilayer high-barrier polypropylene bottle
Perrigo's Chairman and CEO Joseph C. Papa stated, "We are excited to receive FDA clearance on these new liquid concentrate and ready-to-use products and to expand our portfolio of non-powder infant formula products. This is the first launch of new products since acquiring our infant nutrition business and we look forward to further new product introductions."
SOURCE Perrigo Company